1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
In vivo CYP3A activity and pharmacokinetics of imatinib in relation to therapeutic outcome in chronic myeloid leukemia patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
(
- Contribution to journal › Article
- 2011
-
Mark
The Role of Inosine-5'-Monophosphate Dehydrogenase in Thiopurine Metabolism in Patients With Inflammatory Bowel Disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene
(
- Contribution to journal › Article
-
Mark
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.
(
- Contribution to journal › Article
- 2006
-
Mark
Pharmacogenetics during standardised initiation of thiopurine therapy in inflammatory bowel disease.
(
- Contribution to journal › Article
- 2004
-
Mark
Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population.
(
- Contribution to journal › Article
-
Mark
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity.
(
- Contribution to journal › Article
- 1990
-
Mark
Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells
(
- Contribution to journal › Article